Sangamo Therapeutics, Inc SGMO

KhanhC.Hoang

As long as this company has more than 300 employees, I am still its long-term investor using writing its options to generate additional income.

Therealbouga Pro

Bat pattern on SGMO 15 mins. Target 1: 12.62

mzagotti Premium

As noted on the chart, SGMO is displaying a possible rebound play. It has the potential for 20-30 upside. Good Luck...

lauralea Pro

SGMO has retested C and possible ready to move up. Looks almost like a flag, but the flag is getting a bit heavy and is over 3 weeks in formation. SGMO had a big move up, and I guess sometimes if you play, you pay in this market )o: I thought there was a gap overhead, but there is a long wick on top of the green candle. I guess it depends on your definition...

Joshh_Tradess

Down-sloping resistance along horizontal support. Daily hidden bullish divergence on the MACD and RSI 4hr classic bullish divergence on the MACD At 0.618 retrace Stop = Below horizontal support 1st Target = 0.382 extension/resistance 2nd Target = 0.618 extension/resistance

Verum0

Pay for your much needed therapy this week with your profits from a continuation on a SGMOtheraputics breakout. If you missed area of value as outlined by my post last friday we could still be in a good buy position for continuation of this breakout. Safe trading!

mroberts1204 Pro

SGMO is in the gene editing space. Nice setup as it successfully tested the breakout spot and found support. Now launching higher today off key moving averages. CRSP reports earnings this week so we could see a positive catalyst. I took some May $15 calls today.

ETrades1 Pro+

$SGMO has been correcting its 100% surge higher, I believe I have found enough evidence to suggest the $SGMO pullback has completed and represents a great buy opportunity: 1) +1 year long resistance is acting as support 2) reclaiming of the aVWAP from the bottom for the first time in 8 days 3) holding the 50 day EMA 4) consolidation occurring at the 50%...

katblat Premium

grabbed commons with the break in the DT could be too early so starting position is small

katblat Premium

on a break out, i will get in long. Heard great things about this company's fundamentals. I would like to see it confrimed.

paulopicaocapelo Pro

Entry price : 15.02 Fundamentals : - Sector: Medical - Biotech - EPS % Chg (Last Qtr): 95% - EPS % Chg (Previous Qtr): 1% - 3 Year EPS Growth Rate: 0% - EPS Est % Chg (Current Yr): 0% - Sales % Chg (Last Qtr): 163% - Sales % Chg (Previous Qtr): 23% - 3-Year Sales Growth Rate: 54% - Annual Pre -Tax Margin: -93.2%

allthesmokeacquisitioncompany Pro+

support held past few weeks around $15.70. declining volume on sell-off. owns many patents and has deals to bring many CRISPR style medications through development testing and sales. strong revenue growth in a growing and increasingly accepted medical field. potential breakout target of $29. Biotech stocks are high risk as they depend on experiment success or...

KhanhC.Hoang

any pullbacks are additional short-term trades

Joshh_Tradess

Dragon pattern @ horizontal support Daily and 4hr hidden bullish divergence on the MACD and RSI Stop = Below 2nd support 1st Target = Resistance/previous high 2nd Target = 1.618 fib extension

SmoothJB Pro

Sangamo Therapeutics Inc (NASDAQ:SGMO) has been in a consolidation phase in the past two sessions and if the stock is able to move past the strong resistance of 18.64 with good volumes, then it will mean higher levels for the stock. The relative strength line is exhibiting a small negative divergence, which is usually a bearish sign, but in this particular case...

T3metrics Premium

Considering long entry.

KhanhC.Hoang

I'm betting that SGMO will "fly like a duck".

savepiginvest Pro+

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation.